<DOC>
	<DOCNO>NCT00435526</DOCNO>
	<brief_summary>The purpose study assess anti-CFA/I anti-CfaE BIgG safety determine protective efficacy anti-CFA/I anti-CfaE BIgG diarrhea challenge H10407 , CFA/I-expressing ETEC strain .</brief_summary>
	<brief_title>Efficacy Anti-CFA/I CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I</brief_title>
	<detailed_description>This Randomized , double-blinded , placebo-controlled trial involve 33 subject . Subjects randomize one follow three group . Group N Product 1 . 10 BIgG anti-CFA/I 2 . 10 BIgG anti-CfaE 3 . 10 LactoFree® Lipil® Volunteers receive test article three time daily follow meal begin 2 day prior oral ETEC challenge ( strain H10407 ) . Test article administer total 7 day . Monitoring procedure assess volunteer safety , primary endpoint ( diarrhea ) , stool microbiology ( H10407 excretion ) , ETEC-specific immunology . All volunteer receive antibiotic treatment ( ciprofloxacin , trimethoprim-sulfamethoxazole amoxicillin ) start 5 day ETEC challenge sooner base pre-defined clinical criterion . Follow-up visit 2 week post-discharge monitor safety immunological parameter .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Male female 18 45 year age . General good health , without significant medical illness , abnormal physical examination finding clinical laboratory abnormality determine principal investigator . Demonstrate comprehension protocol procedure knowledge ETEC illness pass write examination ( pas grade ≥ 70 % ) Willing participate inform consent obtain . Available planned followup visit . Negative serum pregnancy test screen negative urine pregnancy test day admittance inpatient phase female volunteer childbearing potential . Females childbearing potential must agree use efficacious hormonal barrier method birth control study . Abstinence acceptable . Female volunteer unable bear child must document ( e.g. , tubal ligation hysterectomy ) . Presence significant medical condition , ( e.g . psychiatric condition gastrointestinal disease , peptic ulcer , symptom evidence active gastritis gastroesophageal reflux disease , inflammatory bowel disease , alcohol illicit drug abuse/dependency ) , laboratory abnormality opinion investigator precludes participation study . Immunosuppressive illness IgA deficiency ( normal limit ) Positive serology result HIV , HBsAg , HCV antibody . Significant abnormality screen lab hematology , serum chemistry , urinalysis EKG ( EKG volunteer ≥ 40 year ) , determine PI . Allergy fluoroquinolones , trimethoprimsulfamethoxazole , ampicillin/penicillin ( exclude allergic two three ) . Abnormal stool pattern ( few 3 stool per week 3 stool per day ) regular basis . History diarrhea 2 week prior plan inpatient phase Regular use laxative , antacid , agent low stomach acidity ( regular define least weekly ) . Use antibiotic 7 day dose proton pump inhibitor , H2 blocker , antacid within 48 hour dose . Travel country ETEC cholera infection endemic ( develop world ) within two year prior dose . History vaccination ingestion ETEC , cholera , LT toxin . Stool culture ( collect 1 week prior admission ) positive CFA/I + ETEC bacterial enteric pathogen ( Salmonella , Shigella Campylobacter ) . Use investigational drug investigational vaccine within 30 day precede first dose test article , plan use active study period . Clinical history lactose intolerance allergy milk milk product . Use medication know affect immune function ( e.g. , corticosteroid others ) within 30 day precede first dose study vaccine , plan use active study period . Inability tolerate overthecounter , lactosefree , infant , powder formula suspend 150 mL sodium bicarbonate buffer ( base requirement frequent dosing ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>traveler 's diarrhea</keyword>
	<keyword>ETEC diarrhea</keyword>
	<keyword>passive immunization</keyword>
	<keyword>bovine milk prophylaxis</keyword>
</DOC>